Department of General Surgery, Sanko University School of Medicine, Gaziantep, Turkey.
Department of Emergency Medicine, Biruni University Faculty of Medicine, İstanbul, Turkey.
J Invest Surg. 2022 Nov-Dec;35(11-12):1824-1835. doi: 10.1080/08941939.2022.2128117. Epub 2022 Sep 28.
The objectives of this study were a) to investigate the effect of targeting the PANoptosome with 3,4-methylenedioxy-β-nitrostyrene (MNS) on PANoptosis in the Renal ischemia-reperfussion (RIR) model b) to investigate the kidney protective effect of MNS toward RIR injury.
Thirty-two rats were divided into four groups randomly. The groups were assigned as Control, Sham, DMSO (dimethyl sulfoxide) and MNS groups. The rats in the MNS group were intraperitoneally given 20 mg/kg of MNS 30 minutes before reperfusion. 2% DMSO solvent that dissolves MNS were given to the rats in DMSO group. Left nephrectomy was performed on the rats under anesthesia at the 6th hour after reperfusion. Glutathione peroxidase (GPx), malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD) and 8-Okso-2'-deoksiguanozin (8-OHdG) levels were measured. Immunohistochemical analysis, electron microscopic and histological examinations were carried out in the tissues.
Total tubular injury score was lower in the MNS group ( < 0.001). Caspase-3, Gasdermin D and MLK (Mixed Lineage Kinase Domain Like Pseudokinase) expressions were considerably decreased in the MNS group ( < 0.001). Apoptotic index (AI) was found to be low in the MNS group ( < 0.001). CAT and SOD levels were higher in the MNS Group ( = 0.006, = 0.0004, respectively). GPx, MDA, and 8-OH-dG levels were similar ( > 0.05) in all groups. MNS considerably improved the tissue structure, based on the electron microscopic analysis.
Our results suggested that MNS administrated before the reperfusion reduces pyroptosis, apoptosis and necroptosis. These findings suggest that MNS significantly protects the kidney against RIR injury by reducing PANoptosis as a result of specific inhibition of Nod-like receptor pyrin domain-containing 3 (NLRP 3), one of the PANoptosome proteins.
本研究的目的是 a)研究针对 PANoptosome 的 3,4-亚甲二氧基-β-硝基苯乙烯(MNS)对肾缺血再灌注(RIR)模型中 PANoptosis 的影响,b)研究 MNS 对 RIR 损伤的肾脏保护作用。
32 只大鼠随机分为四组。将这些组分别指定为对照组、假手术组、二甲基亚砜(DMSO)组和 MNS 组。MNS 组的大鼠在再灌注前 30 分钟腹腔内给予 20mg/kg 的 MNS。将溶解 MNS 的 2%DMSO 溶剂给予 DMSO 组的大鼠。再灌注后 6 小时,在麻醉下对大鼠进行左肾切除术。测量谷胱甘肽过氧化物酶(GPx)、丙二醛(MDA)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)和 8-Okso-2'-脱氧鸟苷(8-OHdG)水平。对组织进行免疫组织化学分析、电子显微镜和组织学检查。
MNS 组的总肾小管损伤评分较低(<0.001)。MNS 组 Caspase-3、Gasdermin D 和 MLK(混合谱系激酶结构域样假激酶)表达显著降低(<0.001)。MNS 组的凋亡指数(AI)较低(<0.001)。MNS 组 CAT 和 SOD 水平较高(=0.006,=0.0004,分别)。所有组的 GPx、MDA 和 8-OH-dG 水平相似(>0.05)。根据电子显微镜分析,MNS 显著改善了组织结构。
我们的结果表明,再灌注前给予 MNS 可减少细胞焦亡、细胞凋亡和坏死性凋亡。这些发现表明,MNS 通过特异性抑制 Nod 样受体含吡喃结构域蛋白 3(NLRP3)等 PANoptosome 蛋白之一来减少 PANoptosis,从而显著保护肾脏免受 RIR 损伤。